Controlled Human Infection Challenge Studies involve the deliberate infection of healthy volunteers to support clinical vaccine development, for example for malaria. This webinar will discuss ethical and scientific principles for such studies, outline the risk mitigation steps taken in previous malaria human challenge studies, explore how this might be applied in the context of COVID-19 vaccine development, and address ethical and practical concerns.